Should You Buy AbbVie Stock Ahead of Q3 Earnings Report?
unknown
📅 Published: 2025-10-28 12:48
📰 Source: Yahoo
📝 Words: 25
📝 Article Content
ABBV's Q3 results are likely to hinge on Skyrizi and Rinvoq growth, as Humira erosion and hefty IPR&D charges are expected to pressure near-term earnings.
📄 Summary
ABBV's Q3 results are likely to hinge on Skyrizi and Rinvoq growth, as Humira erosion and hefty IPR&D charges are expected to pressure near-term earnings.
Scraping Metadata:
Scraped At:
Unknown
Created At:
2025-10-30 17:36:25
Updated At:
2025-10-30 17:36:25
Scraping Job ID:
N/A
Stock Mentions:
ABBV - AbbVie Inc.
Relevance: N/A